Ticker brief
BNTX BIONTECH SE-ADR
Consumer, Non-cyclical · Biotechnology
last close
$102.08
1 day
-8.4%
14 days
+9.7%
mkt cap
$24.7B
signals 14d
52
authors 14d
35
crowd 14d
+0.2σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 48% rich · 85 pctile own 1y | IV/HV 0.77× (as of 2026-08-27) |
| Skew — 25Δ RR 30d | +0.022 82 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +0.02 normal | 5-session Δ -0.01 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2026-03-11 (z=3.4) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-28 · now -0.32 (−1 bearish … +1 bullish)
Who spoke35
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Markadiusz45 | C | +1.18 | 5 | +0.42 |
| @Pharmdca | C | +0.82 | 5 | -0.19 |
| @bioinvestor24 | A | -0.45 | 4 | -0.36 |
| @schaeffers | C | +3.18 | 3 | +0.60 |
| @markflowchatter | B | +2.00 | 2 | -0.08 |
| @Brad_E_Schulz | C | · | 2 | +0.70 |
| @toushi_tommy | C | -1.16 | 2 | +0.50 |
| @MarketNews_Feed | C | · | 2 | -0.50 |
| @BankTheTrade | C | +1.63 | 1 | +0.45 |
| @nextbigtrade | B | +1.10 | 1 | +0.45 |
| @KakashiCapital_ | B | -0.15 | 1 | +0.35 |
| @TrendSpider | C | -1.01 | 1 | +0.30 |
| @KampnerSam | A | +0.20 | 1 | +0.20 |
| @semodough | C | -3.01 | 1 | +0.20 |
| @BottomPhishing | B | -1.20 | 1 | +0.30 |
| @IPODave | B | +1.63 | 1 | +0.65 |
| @kunal00 | C | -0.85 | 1 | +0.55 |
| @equitydd | C | -2.03 | 1 | +0.20 |
| @IngJuanPa7 | B | -1.61 | 1 | +0.15 |
| @JensKlattFX | B | +0.50 | 1 | -0.10 |
| @cfaryanoconnell | C | -1.48 | 1 | -0.10 |
| @ClassicRoy | C | -1.52 | 1 | -0.25 |
| @TheOwlsCapital | C | +0.58 | 1 | +0.85 |
| @RichardMoglen | B | -0.93 | 1 | +0.35 |
| @kiantrades | C | +0.69 | 1 | +0.70 |
Recent signals30of 52 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @fwpharma | -0.45 | BioNTech ends a colorectal study of its mRNA vaccine. | — | tweet ↗ |
| 2026-08-28 | @bioinvestor24 | -0.55 | Discloses no MRNA position but a positive trial view, and states a current HK1952 position viewed as undervalued. | — | tweet ↗ |
| 2026-08-28 | @bioinvestor24 | -0.70 | Mocks BNTX's colorectal-cancer strategy and favors MRNA's platform and tumor-selection approach. | — | tweet ↗ |
| 2026-08-28 | @BiotechCH | -0.55 | BNTX announced it is halting its colorectal-cancer vaccine trial. | — | tweet ↗ |
| 2026-08-28 | @ttvresearch | -0.50 | BioNTech ended a Phase 2 colorectal-cancer trial, prompting sharp declines in related biotech shares. | — | tweet ↗ |
| 2026-08-28 | @MarketNews_Feed | -0.50 | BioNTech ended a Phase 2 colorectal-cancer clinical trial. | — | tweet ↗ |
| 2026-08-28 | @MarketNews_Feed | -0.50 | BioNTech stopped a Phase 2 colorectal-cancer trial after a DSMB recommended ending treatment and the study. | — | tweet ↗ |
| 2026-08-28 | @markflowchatter | +0.40 | Praises a Leerink analyst's prior BNTX call but does not specify its terms. | — | tweet ↗ |
| 2026-08-28 | @Tradinguru55 | +0.50 | Pfizer and BioNTech received approval for an updated COVID-19 vaccine. | — | tweet ↗ |
| 2026-08-27 | @HammerstoneMar3 | +0.50 | Pfizer and BioNTech received FDA approval for an XFG-adapted COVID-19 vaccine. | -8.4% | tweet ↗ |
| 2026-08-27 | @faststocknewss | +0.50 | FDA approves updated COVID vaccine formulas from Pfizer-BioNTech and Moderna. | -8.4% | tweet ↗ |
| 2026-08-27 | @EchoAnalysis | +0.70 | States BNTX is close to a potentially violent breakout. | -8.4% | tweet ↗ |
| 2026-08-23 | @fundmyfund | +0.65 | Bullish BNTX sympathy setup seeks a breakout-gap hold and continued upside. | -12.4% | tweet ↗ |
| 2026-08-22 | @toushi_tommy | +0.60 | Summarizes weekly index performance and top and bottom securities. | -12.4% | tweet ↗ |
| 2026-08-22 | @dangerousteee | +0.00 | Reports weekly winners and losers with exact percentage returns by sector. | -12.4% | tweet ↗ |
| 2026-08-21 | @stageanalysis | +0.25 | Screen identifies Stage 2 and continuation-breakout candidates using explicit technical filters. | -12.4% | tweet ↗ |
| 2026-08-21 | @kiantrades | +0.70 | Reports a completed BNTX move from 2.4 to 15 alongside a chart. | -12.4% | tweet ↗ |
| 2026-08-21 | @RichardMoglen | +0.35 | BNTX moved back above a high-volume technical area. | -12.4% | tweet ↗ |
| 2026-08-20 | @TheOwlsCapital | +0.85 | Weekly options recap lists entries, gains and one still-running position. | -7.9% | tweet ↗ |
| 2026-08-20 | @ClassicRoy | -0.25 | Lists equities experiencing increasing unusual put volume. | -7.9% | tweet ↗ |
| 2026-08-20 | @cfaryanoconnell | -0.10 | Lists stocks with increasing unusual put-option volume. | -7.9% | tweet ↗ |
| 2026-08-20 | @Pharmdca | -0.40 | Reports covering a short near $107 after entering near $114 the prior day. | -7.9% | tweet ↗ |
| 2026-08-20 | @JensKlattFX | -0.10 | Maps public cancer-vaccine peers, sympathy moves, clinical prospects, and M&A potential | -7.9% | tweet ↗ |
| 2026-08-20 | @IngJuanPa7 | +0.15 | MRK-MRNA personalized cancer vaccine met endpoints in a 1,000-plus-patient late-stage trial. | -7.9% | tweet ↗ |
| 2026-08-20 | @Markadiusz45 | +0.50 | Portfolio update discloses stopped positions, new biotech longs and partial BNTX derisking. | -7.9% | tweet ↗ |
| 2026-08-19 | @equitydd | +0.20 | Lists the day's leading gainers; ticker extraction is capped at the first six. | -9.8% | tweet ↗ |
| 2026-08-19 | @bioinvestor24 | +0.05 | Quotes Everest's CEO claiming end-to-end mRNA and in-vivo CAR-T capabilities comparable with large peers. | -9.8% | tweet ↗ |
| 2026-08-19 | @bioinvestor24 | -0.25 | Says private Everest's platform is better than BioNTech's. | -9.8% | tweet ↗ |
| 2026-08-19 | @kunal00 | +0.55 | Frames QE, biotech, crypto and software rotation while presenting a next-day watchlist. | -9.8% | tweet ↗ |
| 2026-08-19 | @schaeffers | +0.60 | Reports successful Phase 3 melanoma results and quantified peer and sector gains. | -9.8% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.